$3.570
-0.020 (-0.56%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
PRME 相似图表分析预测
Alphio's PRME stock price prediction model matches the current Prime Medicine, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.48 (-2.66%). The 1-week path is $3.49 (-2.16%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Prime Medicine, Inc 股票吗？
Prime Medicine Inc is a good buy right now due to its recent 6.49% increase over the last 5 days and a favorable RSI of 61.217, indicating bullish momentum. The positive arbitration ruling against Beam Therapeutics has removed a significant overhang, allowing the company to advance its PM647 treatment, which is expected to enter clinical trials soon. However, the main risk is the company's ongoing net losses, with a net income of -42,109,000 USD in Q2 2026, which highlights the financial challenges it faces as it seeks to commercialize its technology.
PRME 股价于 Tuesday 收于 $3.57，此前下跌 -0.56%
Prime Medicine, Inc (PRME) last closed at $3.57, losing -0.56%. These facts feed the 1-day and 1-week PRME price prediction above.
预测驱动因素
Prime Medicine, Inc（PRME）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
相似图表形态
近期走势与 PRME 最接近的股票，按相似度排序。
PRME 季节性分析
Historically the probability of a positive September return for PRME is 52.38%. January offers the highest probability of a positive month at 52.46%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。